Facile synthesis of fused pyrazolo[1,5-a]pyrimidinepyrazolo [1,5-a]triazines and N-sulphonamidopyrazoles as antiinflammatory

Acta Poloniae Pharmaceutica - Drug Research

Volumn 60, Issue 1, 2003, Pages 51-60

  Fathalla, O A ^b   Zaki, M E A ^b   Swelam, S A ^b   Nofal, S M ^a   El Eraky, W I ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b NONE

Author keywords

Antiinflammatory; N sulphon amidopyrazoles; Pyrazolo 1,5 a pyrimidines and triazines

Indexed keywords

5 AMINO 3 [(1,5 DIMETHYL 3 OXO 2 PHENYL 2,3 DIHYDRO 1H PYRAZOL 4 YL)AMINO] 1 PHENYL PYRAZOL 4 CARBONITRILE; 5 AMINO 3 [(1,5 DIMETHYL 3 OXO 2 PHENYL 2,3 DIHYDRO 1H PYRAZOL 4 YL)AMINO] 1H PYRAZOLE 4 CARBONITRILE; ACRYLIC ACID DERIVATIVE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ANTIPYRETIC AGENT; CARBOXYLIC ACID DERIVATIVE; DIPYRONE; HYDRAZINE; MELOXICAM; METHYL 5 AMINO 3 [(1,5 DIMETHYL 3 OXO 2 PHENYL 2,3 DIHYDRO 1H PYRAZOL 4 YL)AMINO] 1 PHENYLPYRAZOL 4 CARBOXYLIC ACID; METHYL 5 AMINO 3 [(1,5 DIMETHYL 3 OXO 2 PHENYL 2,3 DIHYDRO 1H PYRAZOL 4 YL)AMINO] 1H PYRAZOLE 4 CARBOXYLIC ACID; METHYL GROUP; N SULPHONAMIDOPYRAZOLE; NITRILE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENAZONE; PHENYLBUTAZONE; PIROXICAM; PURINE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRAZOLINE DERIVATIVE; PYRAZOLO[1,5 A]PYRIMIDINEPYRAZOLO[1,5 A]TRIAZINE; PYRAZOLOPYRIMIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; ARTICLE; CHEMICAL INTERACTION; CHEMICAL REACTION; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; MALE; NONHUMAN; RAT; ULCEROGENESIS;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; EDEMA; FEVER; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; PAIN MEASUREMENT; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; STOMACH ULCER; TRIAZINES;

EID: 0037950585     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Vane J.R.: Nature 231, 232 (1971).
2. Li J.J., Noton M.B., Reinhard E.J., Anderson G.D., Gregoy S.A., Isakson P.C., Koboldt C.M., Masferrer J.L., Perkins W.E., Seibert K., Zhang Y., Zweigel B.S., Reitz D.B.: J. Med. Chem. 39, 1846 (1996).
3. Lambardino J., Wiseman E.: J. Med. Chem. 15, 848 (1972).
4. Traalitz G., Engel W., Seeger E., Engethardt G.: Ger. Off. 2, 756, 113; ref. Chem. Abstr. 91, 91656m (1979).
5. Alexander Y.O., Wheeler G., Rhill P.O., Morris M.P.: Biochem. Pharmacol. 15, 881 (1966).
6. Elion G.B., Gallaham S., Ualhan H., Bicher S., Randles R.W., Hitcgings G.H.: Biochem. Pharmacol. 12, 65 (1963).
7. Earl R. et al.: J. Chem. 40, 1822 (1975).
8. Fathala O.A., Zaki M.E.A.: Indian J. Chem. 37B, 484 (1998).
9. Winter C.A., Risley E.A., Nus G.W.: Proc. Soc. Exp. Biol. Med. III, 544 (1962).
10. Turner A.R.: Academic Press, New York, London, 120 pp. (1968).
11. Charlier R., Prost M., Binon F., Deltour G.: Arch. Intern. Pharmacodyn. 134, 306 (1961).
12. Manasse R., Hedwalin P.R., Kraetz J., Pericin C., Rieleres L., Salmann A., Ziel R., Jaques R.: Scand. J. Rheumatol. Suppl. 22, 5 (1978).
13. Correl T., Moller J.K., Pawinski: Acta Pharmacol. Toxicol. 45, 232 (1979).
14. Snedecor W.G., Cochran G.W.: Iowa State University Press. Ames Iowa (1971).
15. Shalaby A.M., Fathalla O.A., Kassem E.M.M., Zaki M.E.A.: Acta Chem. Slov. 47, 187 (2000).
16. Zaki E.M.A., Fathala O.A.: Indian. J. Heterocycl. Chem. 7 (2) Oct.-Dec., 113 (1997).
17. Ammar Y.A., El-Sharief A.M., Zohran M.A., Zaki M.E.A.: J. Chem. Res. (s), 324 (1995).
18. Zaki M.E.A., Shalaby A.M.: Indian J. Heterocyc. Chem. 6 (3), 189 (1997).
19. Nevine A., Abdalla, Zaki M.A.E.: Acta Pharm. 49, 159 (1999).
20. Nagahora A.K., Kawano H., Sascoka S.H., Ukawa C.H., Hiram H., Takada A., Cottain H.B., Robins R.R.: J. Heterocyc. Chem. 31, 23 (1994).
21. Elangdi M.H., Fleite H.D., Elmoghayer R.H.: Tetrahedron 31, 63 (1975).